{
  "id": "regulatory-competitive-intel-briefing",
  "title": "Regulatory and Competitive Intelligence Briefing",
  "category": "executive_prompts",
  "author": "Frederick de Ruiter",
  "created": "2025-07-18",
  "last_modified": "2025-07-18",
  "tested_model": "gpt-4o",
  "temperature": 0.2,
  "tags": [
    "executive",
    "regulatory"
  ],
  "prompt": {
    "purpose": "Provide a Monday-morning briefing on regulatory changes and competitor moves that may affect decentralized and hybrid trials.",
    "context": "Role: Senior regulatory-affairs strategist briefing the CRO President. Regions include FDA (US), EMA (EU), MHRA (UK), and PMDA (Japan). Timeframe covers the past 90 days.",
    "instructions": "- Gather and synthesize newly issued or updated guidance documents, enforcement actions, and competitor announcements such as acquisitions or large DCT partnerships.\n- For each item include:\n   - \u201cWhat changed\u201d (\u226425 words)\n   - \u201cWhy it matters to CROs\u201d (\u226435 words)\n   - \u201cAction for {{company_name}}\u201d (\u226425 words)\n- Group findings under the headers \u201cRegulatory Shifts\u201d and \u201cCompetitive Moves.\u201d\n- End with a bulleted \u201cRecommended Next Steps\u201d list (max five bullets) prioritized by impact (High/Med/Low).\n- Write in a concise, executive tone without jargon.",
    "inputs": "- `{{company_name}}` \u2013 name of the CRO.",
    "output_format": "Markdown sections:\n\n```",
    "additional_notes": "Keep the briefing short and focused on actionable insights.",
    "example_usage": "",
    "references": ""
  }
}